The Immune System’s Rulebook Breaks
For decades, the central nervous system was treated as sealed territory. The blood-brain barrier stood guard, the immune system sorted self from foreign, and the brain was assumed to contain only cells built from its own DNA. That model has now collided with its own data. Maternal DNA turns up inside the brain tissue of children with epilepsy, and RNA read from those same samples shows the foreign cells have not stayed inert. They have taken on identities: neurons, immune cells, blood vessel cells, and supporting cells called astrocytes. Sami Kanaan at the Fred Hutchinson Cancer Center in Seattle calls the range of identities a surprise, found in both healthy and diseased cohorts. [1] The passenger, it turns out, has a job description.
The process behind this is microchimerism — a long word for a simple exchange. During pregnancy, maternal cells cross the placenta into the fetus, while fetal cells travel the other direction into the mother. Some of them stay for years. The traffic runs both ways, like two households that never quite finish moving furniture between them. The 2008 detection of maternal cells in human fetal brain tissue, and the 2012 finding of male DNA in women’s brains — probably left by pregnancies with male fetuses — established that the delivery happens. What remained open was what the delivered cells become.
The new work, a preprint not yet peer-reviewed, brings us closer to answering part of that by reading the cells’ RNA — the instruction manual a cell is actively running. The maternal cells had diversified into a cast spanning neuronal, glial, immune and vascular roles, the researchers reported. A foreign cell does not merely survive in the brain. It appears to take on the brain’s own identities.
What the Mice Already Knew
Animal work had arrived at a related answer first, and in hindsight it looks less like a curiosity and more like a preview. In 2022, researchers compared mice carrying reduced numbers of maternal cells with mice carrying typical levels. The low-cell mice showed disrupted communication between the prefrontal cortex and the hippocampus — regions tied to planning and memory — and performed worse on tasks requiring recall of previously learned information. The maternal cells, the results suggested, help regulate the brain’s resident immune cells and prevent excessive pruning of connections between neurons.
Kanaan is careful about the leap from mouse to human. Whether comparable mechanisms operate in people, he says, remains an open question. [1] But he is willing to speculate, and the speculation has a floor under it: human evidence already shows maternal cells influencing the developing immune system, so in his view extending that influence to the brain is a reasonable expectation rather than a leap of faith.
The reverse traffic may carry its own function. Kanaan points to a mouse experiment in which enhanced recruitment of fetal cells accompanied reduced brain injury and changes consistent with repair. Here the direction of the exchange matters: cells that migrated from child to mother appear to gather at damage. The same logic has been suggested for humans. The 2012 study detected male DNA in the brains of 37 of 59 women, and reported a lower prevalence among those with Alzheimer’s — a pattern consistent with protection, though the design could not establish cause and effect. The disease itself might have influenced whether those cells persisted.
That ambiguity is the field’s recurring tax. Microchimeric cells have been associated with Parkinson’s disease, multiple sclerosis, stroke and brain tumours, and in every case the question is the same: are these cells contributing to the condition, or have they been recruited to repair it? A firefighter at a fire and an arsonist at a fire leave similar footprints.
An Evolutionary Bargain With Strings
Evolution adds a frame that no microscope can supply. David Haig at Harvard University argues that mothers and their children share an evolutionary interest in each other’s well-being, so natural selection may tend to eliminate harmful effects of this cellular exchange and favour beneficial ones. Their interests do not always align, though, especially over how a mother’s resources get shared. Offspring cells in a mother’s brain, he suggests, may promote care and attachment toward the child they came from, while maternal cells in an offspring’s brain may favour cooperation toward the mother and with other siblings.
The numbers expose how little is settled. In Kanaan’s study, maternal cells appeared in the majority of samples, but the density varied enormously: some samples held around 2.2 maternal cells per 100,000, others up to 458.9 per 100,000. Asked why, Haig is blunt: \"The answer is no, we do not know.\” [1] He suspects genetic factors. Cells carry proteins that let the immune system recognise self from foreign, and levels of recognition and tolerance vary, which may influence how many microchimeric cells survive. Medical history may matter too: pre-eclampsia, a dangerous condition of high blood pressure in pregnancy, increases the permeability of the blood-brain barrier and may let more fetal cells cross into a mother’s brain. Some of the spread may be an artefact of sampling — one region can hold more cells than another, so a negative sample does not prove absence elsewhere.
